Implant and coating to reduce osteolysis
US-2021290822-A1 · Sep 23, 2021 · US
US12090249B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12090249-B2 |
| Application number | US-202117202527-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 16, 2021 |
| Priority date | Oct 6, 2015 |
| Publication date | Sep 17, 2024 |
| Grant date | Sep 17, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An implant is provided comprising a substrate having one or more nanoceria coatings coated at least partially thereon, wherein the one or more nanoceria coatings comprise surface cerium having a 3+/4+ oxidation state ratio such that the one or more nanoceria coatings exhibit catalase mimetic activity, superoxide dismutase mimetic activity, or both. Methods are provided for forming a nanoceria coating. The coating has nanoceria having a surface cerium 3+/4+ oxidation state ratio such that such that the coating exhibits catalase mimetic activity, superoxide dismutase mimetic activity, or both. Also disclosed is a method of reducing degradation of an implant by placing nanoceria in proximity to a bone-implant interface.
Opening claim text (preview).
What is claimed is: 1. A method for forming a coating comprising steps of: providing a substrate; and electrophoretically forming the coating on at least a portion of the substrate using a dispersion; wherein the dispersion comprises ceria nanoparticles with cerium predominantly in a Ce 3+ oxidation state on the surface thereof (NC1) or the ceria nanoparticles with cerium predominantly in a higher Ce 4+ oxidation state on the surface thereof (NC2), or a mixture of NC1 and NC2; wherein NC1 and NC2 comprise the ceria nanoparticles having a size in a range of 3-5 nm; and wherein the coating exhibits catalase mimetic activity, superoxide dismutase mimetic activity, or both. 2. The method of claim 1 , wherein the electrophoretic forming step is carried out by applying a voltage having a DC component and/or an AC component to the substrate and at least one counter-electrode, wherein the voltage is continuous, pulsed, or arbitrarily increasing or decreasing with time. 3. The method of claim 2 , wherein the at least one counter-electrode comprises two counter-electrodes. 4. The method of claim 1 , further comprising after the coating has been formed, heating the substrate to 200-450° C. for 1-2.5 hr. 5. The method as recited in claim 1 , wherein one electrode is a Ti electrode and two electrodes are nonconsumable counter-electrodes. 6. The method of claim 1 , wherein the substrate comprises a prosthesis.
for joint reconstruction · CPC title
Methods for coating medical devices · CPC title
Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Macromolecular materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.